Statin and Inflammatory Breast Cancer

General, Physician Resources

The following is an introduction written by Dr. Ueno director of the Morgan Welch Clinic at MD Anderson commenting on an article ran in Science November 29, 2013.   We are very familiar with the desire of Dr. Ueno to research how statin can impact recurrence of breast...

The Death of Research As We Know It?

General

The following article was published in Breast Investigators in January of 2013.  However, I wanted to post it on our blog after listening to comments by a speaker at the MD Anderson Network conference today.  The speaker was a Pulitzer prize winner, Siddhartha...

Inflammatory Breast Cancer: What We Know and What We Need to Learn

Patient Resources, Physician Resources

Simply titled, Inflammatory Breast Cancer: What We Know and What We Need to Learn, is a review of the current status of multidisciplinary care for patients with inflammatory breast cancer (IBC) and discusses what further research is needed to advance the care of...

Jan, celebrating 6 years, NED.

Stories of Hope - App

Today I am celebrating my 6 year cancer anniversary—a survivor of Stage IIIb, HER2+ Inflammatory Breast Cancer. I give credit for my survival to the miracle drug, Herceptin, and early detection—as early can be with IBC.  Amazingly, only one node was positive! Since...

F.D.A. Approves a New Drug for Advanced Breast Cancer

Patient Resources

The Food and Drug Administration approved a new type of drug that combines the widely used breast cancer medicine Herceptin with a powerful toxin to more effectively kill cancer cells while potentially reducing side effects.  The drug, which will be called Kadcyla but...